Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.0510
0.00 (0.00%)
Jan 20, 2026, 4:00 PM EST

Bio Essence Statistics

Total Valuation

Bio Essence has a market cap or net worth of 1.94 million. The enterprise value is 4.35 million.

Market Cap1.94M
Enterprise Value 4.35M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date Mar 27, 2026
Ex-Dividend Date n/a

Share Statistics

Bio Essence has 38.01 million shares outstanding. The number of shares has increased by 5.50% in one year.

Current Share Class 38.01M
Shares Outstanding 38.01M
Shares Change (YoY) +5.50%
Shares Change (QoQ) n/a
Owned by Insiders (%) 90.49%
Owned by Institutions (%) n/a
Float 3.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.43
PB Ratio -0.62
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio 2.58
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -27.11
EV / Sales 7.69
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio 0.06
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -57.64

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -17.46%
Return on Invested Capital (ROIC) -42.08%
Return on Capital Employed (ROCE) 4.13%
Revenue Per Employee 282,834
Profits Per Employee -80,227
Employee Count2
Asset Turnover 1.26
Inventory Turnover n/a

Taxes

In the past 12 months, Bio Essence has paid 800 in taxes.

Income Tax 800
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -79.91% in the last 52 weeks. The beta is 11.33, so Bio Essence's price volatility has been higher than the market average.

Beta (5Y) 11.33
52-Week Price Change -79.91%
50-Day Moving Average 0.12
200-Day Moving Average 0.89
Relative Strength Index (RSI) 34.59
Average Volume (20 Days) 4,910

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.89

Income Statement

In the last 12 months, Bio Essence had revenue of 565,667 and -160,453 in losses. Loss per share was -0.00.

Revenue565,667
Gross Profit 391,890
Operating Income -125,764
Pretax Income -159,653
Net Income -160,453
EBITDA -125,295
EBIT -125,764
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 28,741 in cash and 2.44 million in debt, with a net cash position of -2.41 million or -0.06 per share.

Cash & Cash Equivalents 28,741
Total Debt 2.44M
Net Cash -2.41M
Net Cash Per Share -0.06
Equity (Book Value) -3.10M
Book Value Per Share -0.08
Working Capital -3.05M
Full Balance Sheet

Cash Flow

Operating Cash Flow 751,767
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 69.28%, with operating and profit margins of -22.23% and -28.37%.

Gross Margin 69.28%
Operating Margin -22.23%
Pretax Margin -28.22%
Profit Margin -28.37%
EBITDA Margin -22.15%
EBIT Margin -22.23%
FCF Margin n/a

Dividends & Yields

Bio Essence does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.50%
Shareholder Yield -5.50%
Earnings Yield -8.28%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Bio Essence has an Altman Z-Score of -94.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -94.63
Piotroski F-Score 3